Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
出版年份 2015 全文链接
标题
Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
作者
关键词
Bladder cancer, Dapagliflozin, Hematuria, SGLT2 inhibitor, Type 2 diabetes mellitus
出版物
Diabetes Therapy
Volume 6, Issue 3, Pages 357-375
出版商
Springer Nature
发表日期
2015-08-31
DOI
10.1007/s13300-015-0128-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sex-, Species-, and Tissue-Specific Metabolism of Empagliflozin in Male Mouse Kidney Forms an Unstable Hemiacetal Metabolite (M466/2) That Degrades to 4-Hydroxycrotonaldehyde, a Reactive and Cytotoxic Species
- (2015) Mitchell E. Taub et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Evaluating Hematuria: Impact of Guideline Adherence on Urologic Cancer Diagnosis
- (2014) Atul B. Shinagare et al. AMERICAN JOURNAL OF MEDICINE
- Variation in the Intensity of Hematuria Evaluation: A Target for Primary Care Quality Improvement
- (2014) David F. Friedlander et al. AMERICAN JOURNAL OF MEDICINE
- Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study
- (2014) S H Vermeulen et al. BRITISH JOURNAL OF CANCER
- Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin
- (2014) Sandra De Jonghe et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys
- (2014) D. Roy et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonists and pancreatitis: A meta-analysis of randomized clinical trials
- (2014) Matteo Monami et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension
- (2014) Lawrence A. Leiter et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression
- (2014) Hiroaki Kobayashi et al. BMC Urology
- Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
- (2014) L. Li et al. BMJ-British Medical Journal
- Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus
- (2014) Timothy P. Reilly et al. Diabetes Therapy
- Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin
- (2013) John P.H. Wilding ANNALS OF INTERNAL MEDICINE
- Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
- (2013) Zhaowei Zhu et al. BMC CANCER
- Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
- (2013) Clifford J Bailey et al. BMC Medicine
- Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
- (2013) Markolf Hanefeld et al. Current Diabetes Reports
- Diabetes Mellitus Increases the Risk of Bladder Cancer: An Updated Meta-Analysis of Observational Studies
- (2013) Hong Fang et al. Diabetes Technology & Therapeutics
- Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus
- (2013) Muhammad Abdul-Ghani et al. Endocrine Practice
- Nonclinical Toxicology Assessments Support the Chronic Safety of Dapagliflozin, a First-in-Class Sodium-Glucose Cotransporter 2 Inhibitor
- (2013) Mark Tirmenstein et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Peroxisome Proliferator-Activated Receptor Agonists and Bladder Cancer: Lessons from Animal Studies
- (2013) CHIN-HSIAO TSENG et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS
- Pioglitazone and bladder cancer: a propensity score matched cohort study
- (2012) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical features of bladder cancer in primary care
- (2012) Elizabeth A Shephard et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
- (2012) Muhammad A. Abdul-Ghani et al. Current Diabetes Reports
- Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
- (2012) J. Rosenstock et al. DIABETES CARE
- Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial
- (2012) K. Kaku et al. DIABETES OBESITY & METABOLISM
- A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer
- (2012) Carlos Alves et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study
- (2012) Christina C. Newton et al. INTERNATIONAL JOURNAL OF CANCER
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial
- (2011) M. A. Nauck et al. DIABETES CARE
- Long-term effects of insulin glargine on the risk of breast cancer
- (2011) S. Suissa et al. DIABETOLOGIA
- Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETOLOGIA
- Diabetes and risk of bladder cancer
- (2010) Todd MacKenzie et al. CANCER
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- SMOKING AND UROLOGICAL DISEASE
- (2009) Paul Crow et al. BJU INTERNATIONAL
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
- (2009) Dalsu Baris et al. JNCI-Journal of the National Cancer Institute
- Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction
- (2008) L. Tian et al. BIOSTATISTICS
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey
- (2008) Alan M. Nieder et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Patterns of Hematuria Referral to Urologists: Does a Gender Disparity Exist?
- (2008) Emilie K. Johnson et al. UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started